Tag: MDMA therapy

MDMA-assisted therapy showed extraordinary promise in Phase 3 trials for PTSD before a landmark 2024 FDA rejection. This review explains the science, the setback, and why this approach remains among the most important ongoing areas of research for treating trauma-driven addiction.

Psychedelic therapy research is undergoing a renaissance, with rigorous clinical trials demonstrating that compounds like psilocybin and MDMA may offer breakthrough treatment for addiction. Learn what the science actually shows and how these findings may shape future care.